Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haiwa Wu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|September 16, 2018
Microfluidic-Based Single-Cell Study: Current Status and Future PerspectiveHaiwa Wu, Jing Zhu, Yao Huang, et al.
American Journal of Hematology|December 12, 2017
No major differences in outcomes between the initial and relapse episodes in patients with thrombotic thrombocytopenic purpura: The experience from the Ohio State University RegistryCamila Masias, Haiwa Wu, Michael McGookey, et al.
British Journal of Haematology|February 18, 2020
Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpuraHaiwa Wu, Lauren Jay, Shili Lin, et al.
Polymers|June 6, 2019
Optimized Synthesis of Biodegradable Elastomer PEGylated Poly(glycerol sebacate) and Their Biomedical ApplicationYanxiang Wang, Haiwa Wu, Zihao Wang, et al.
Blood Advances|January 4, 2018
Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpuraSpero R Cataland, Peter J Kourlas, Shangbin Yang, et al.
Blood Advances|October 18, 2018
Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHDSarah A Wall, Qiuhong Zhao, Martha Yearsley, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|September 16, 2018
Microfluidic-Based Single-Cell Study: Current Status and Future PerspectiveHaiwa Wu, Jing Zhu, Yao Huang, et al.
American Journal of Hematology|December 12, 2017
No major differences in outcomes between the initial and relapse episodes in patients with thrombotic thrombocytopenic purpura: The experience from the Ohio State University RegistryCamila Masias, Haiwa Wu, Michael McGookey, et al.
British Journal of Haematology|February 18, 2020
Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpuraHaiwa Wu, Lauren Jay, Shili Lin, et al.
Polymers|June 6, 2019
Optimized Synthesis of Biodegradable Elastomer PEGylated Poly(glycerol sebacate) and Their Biomedical ApplicationYanxiang Wang, Haiwa Wu, Zihao Wang, et al.
Blood Advances|January 4, 2018
Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpuraSpero R Cataland, Peter J Kourlas, Shangbin Yang, et al.
Blood Advances|October 18, 2018
Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHDSarah A Wall, Qiuhong Zhao, Martha Yearsley, et al.
Pageof 1